A 51-year-old woman constitutionally susceptible to allergy presented
with acute allergic liver injury. She was taking tegafur for treatment
of carcinoma of the uterus. The acute liver injury appeared 3 weeks a
fter the first drug administration. She had marked elevation of glutam
ic oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (G
PT), moderate jaundice, and eosinophilia. The virus markers revealed h
epatitis B surface antigen (HBsAg) (-) antibody to hepatitis B surface
antigen (HBsAb) (+), and immunoglobulin M HA antibody (IgM HA Ab) (-)
. The laparoscopic and histologic findings were compatible with drug-i
nduced liver injury. Further, the results of the lymphocyte stimulatio
n test (LST) and challenge test by tegafur were positive. From the abo
ve findings, the liver injury was diagnosed to be an allergic reaction
induced by tegafur. The hepatic function returned to normal about 20
days after tegafur administration was suspended. Allergic liver injury
induced by tegafur is very rare. We report the case with a short revi
ew of the literature.